MBX Biosciences, Inc.
MBX
$8.70
$0.070.81%
09/30/2024 | 06/30/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 26.66% | -0.13% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 17.73% | 25.12% | |||
Operating Income | -17.73% | -25.12% | |||
Income Before Tax | -14.41% | -28.53% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -14.41% | -28.53% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -14.41% | -28.53% | |||
EBIT | -17.73% | -25.12% | |||
EBITDA | -17.73% | -25.09% | |||
EPS Basic | -165.26% | -22.99% | |||
Normalized Basic EPS | -165.23% | -23.00% | |||
EPS Diluted | -165.26% | -22.99% | |||
Normalized Diluted EPS | -165.23% | -23.00% | |||
Average Basic Shares Outstanding | -56.87% | 4.50% | |||
Average Diluted Shares Outstanding | -56.87% | 4.50% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |